A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2011
12/20/2011	US8080060 Processes and systems for loading medical implants with simulative growth agents
12/20/2011	CA2598510C Q3 sparc deletion mutant and uses thereof
12/20/2011	CA2488695C Cell-permeable peptide inhibitors of the jnk signal transduction pathway
12/20/2011	CA2463549C Use of thymulin-like peptides for making pain-relieving medicines
12/20/2011	CA2457372C Composition for filling bone defects
12/20/2011	CA2447450C Corona-virus-like particles comprising functionally deleted genomes
12/20/2011	CA2423045C Adenoviral vectors for gene delivery in skeletal muscle cells or myoblasts
12/20/2011	CA2386858C 36p6d5: secreted tumor antigen
12/20/2011	CA2346219C Treatment of nervous tissue following disease or injury
12/20/2011	CA2329754C Peptide composition as immunogen for the treatment of allergy
12/20/2011	CA2321161C Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
12/20/2011	CA2202028C Tie-2 ligands, methods of making and uses thereof
12/20/2011	CA1341625C Recombinant mammalian gm-csf, dna encoding mammalian gm-scf and methods of use thereof
12/15/2011	WO2011156820A2 Compositions, methods and uses for treatment of type 1 diabetes
12/15/2011	WO2011156802A1 Topical skin cream comprising phosphatidycholine dha and l-tyrosine
12/15/2011	WO2011156761A1 Methods and systems for adenovirus interaction with desmoglein 2 (dsg2)
12/15/2011	WO2011156751A2 Immunogenic vaccine
12/15/2011	WO2011156747A1 Nucleic acid encoding fusion polypeptides that prevent or inhibit hiv infection
12/15/2011	WO2011156736A2 Targeted mucosal treatment of obesity and diabetes
12/15/2011	WO2011156729A2 Methods of mitigating effects of radiation and reducing the risk of systemic infection
12/15/2011	WO2011156715A2 Methods of treating metabolic disorders and cardiovascular diseases
12/15/2011	WO2011156711A1 Nanoparticle film delivery systems
12/15/2011	WO2011156686A2 Method for synthesizing a cyclic multivalent peptide using a thiol-mediated reaction
12/15/2011	WO2011156655A2 Novel glp-1 receptor stabilizers and modulators
12/15/2011	WO2011156637A1 Pphox and rubicon peptides and methods of use
12/15/2011	WO2011156476A2 Insulin with a basal release profile
12/15/2011	WO2011156453A2 Therapeutic peptides
12/15/2011	WO2011156407A2 Glp-1 receptor agonists to treat pancre-atitis
12/15/2011	WO2011156329A2 Methods of treating pain and morphine tolerance via modulation of hedgehog signalling pathway
12/15/2011	WO2011156242A2 Improved anti-lysophospholipid antibody design using antibody structures
12/15/2011	WO2011156061A1 Preparation of crystalline ezatiostat hydrochloride ansolvate form d
12/15/2011	WO2011156045A2 Tablet formulation of ezatiostat
12/15/2011	WO2011156025A1 Crystalline Ezatiostat Hydrochloride Ansolvate
12/15/2011	WO2011156002A1 A heterogeneous inseminate system
12/15/2011	WO2011156000A2 Use of il-4/il-13 antagonists to treat eosinophilic disorders
12/15/2011	WO2011155853A1 Peptides, constructs and uses therefor
12/15/2011	WO2011155727A2 Method for preventing and treating infection caused by salmonella choleraesuis or salmonella dublin
12/15/2011	WO2011155643A1 Phosphatidylinositol 3-kinases activity regulator including the fifth zinc finger domain of fog2
12/15/2011	WO2011155641A1 Method for producing erythropoietin, and method for isolating erythropoietin-producing cells
12/15/2011	WO2011154887A1 Mellitin for the use thereof in the treatment of parkinson's disease
12/15/2011	WO2011154882A1 Induction of bone formation
12/15/2011	WO2011154525A1 Antimicrobial peptide variants and polynucleotides encoding same
12/15/2011	WO2011154403A2 Isolation of mesenchymal stem cells
12/15/2011	WO2011154359A1 Novel auristatin derivatives and use thereof
12/15/2011	WO2011154349A2 Fgf21 analogues and derivatives
12/15/2011	WO2011154308A1 New compositions and cell therapy methods for the treatment of cirrhosis
12/15/2011	WO2011153965A1 Fusion protein of exendin-4 and its analog, preparation method and use thereof
12/15/2011	WO2011153817A1 Cyclopeptides used as melanocortin-4 receptor agonist
12/15/2011	WO2011153815A1 Sialic acid (α-(2→6)-d-aminopyranose derivatives, synthesis methods and uses thereof
12/15/2011	WO2011153763A1 Mixture of t cell immune balance peptides
12/15/2011	WO2011153642A1 Leptin and leptin analog conjugates and fusion proteins and uses thereof
12/15/2011	WO2011153590A1 Use of interferon epsilon in methods of diagnosis and treatment
12/15/2011	WO2011153583A1 Nociceptin mimetics
12/15/2011	WO2011134478A3 Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof
12/15/2011	WO2011127288A3 Methods and uses of nur77 and nur77 agonists
12/15/2011	WO2011123041A8 Fertilization prediction and promotion
12/15/2011	WO2011113013A3 Methods and compositions for treating viral or virally-induced conditions
12/15/2011	WO2011096756A3 Pharmaceutical composition for inhibiting abnormal proliferation of cells
12/15/2011	WO2011091401A9 Treatment of immune disorders using kainate receptor antagonists
12/15/2011	WO2011091027A3 Recombinant live attenuated foot-and-mouth disease (fmd) vaccine containing mutations in the l protein coding region
12/15/2011	US20110307074 Biomaterials for use in methods of bone replacement therapy
12/15/2011	US20110306756 Prevention and Treatment of Amyloidogenic Disease
12/15/2011	US20110306752 Mutant interleukin-2 (il-2) polypeptides
12/15/2011	US20110306657 Polyalkyleneimine-graft-biodegradable polymers for delivery of bioactive agents
12/15/2011	US20110306651 Rna interference mediating small rna molecules
12/15/2011	US20110306565 Hyaluronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation
12/15/2011	US20110306564 Solid composition, microparticles, microparticle dispersion liquid, and manufacturing methods for these
12/15/2011	US20110306563 Macrolactone derivatives, method for the production thereof and use thereof for the treatment of cancer
12/15/2011	US20110306562 Antisense EGFRAS Guanidinium Peptide Nucleic Acid (GPNA) Oligonucleotides as Antitumor Agents
12/15/2011	US20110306561 COMPLEMENT C3a DERIVED DIMERIC PEPTIDES AND USES THEREOF
12/15/2011	US20110306560 Boronic ester and acid compounds, synthesis and uses
12/15/2011	US20110306559 Methods and compositions for treating neuropathic pain
12/15/2011	US20110306558 Prosaposin as a neurotrophic factor
12/15/2011	US20110306557 Neural regeneration peptides and methods for their use in treatment of brain damage
12/15/2011	US20110306556 Neuroprotection from brain anoxia and reperfusion injury during stroke and compositions of pkg pathway activators and method of use thereof
12/15/2011	US20110306555 Biologic replacement for fibrin clot
12/15/2011	US20110306554 Peptide capable of binding to immunoglobulin
12/15/2011	US20110306553 Methods and uses involving heme binding protein 1
12/15/2011	US20110306552 Pyrimidinone inhibitors of lipoprotein-associated phospholipase a2
12/15/2011	US20110306551 Modification of Factor VIII
12/15/2011	US20110306550 Apoe analogs and methods for their use
12/15/2011	US20110306549 Glp-1 receptor agonists to treat pancreatitis
12/15/2011	US20110306548 Stable growth hormone compounds
12/15/2011	US20110306547 Lhrh - antagonists in the treatment of fertility disorders
12/15/2011	US20110306546 Compositions for increasing hair growth and decreasing hair loss
12/15/2011	US20110306545 Novel peptides for wound healing
12/15/2011	US20110306544 Methods and formulations for increasing intestinal function
12/15/2011	US20110306543 Combination of insulin with triazine derivatives and its use for treating diabetes
12/15/2011	US20110306542 Novel glp-1 receptor stabilizers and modulators
12/15/2011	US20110306541 Methods for treating hcv
12/15/2011	US20110306540 Use of Leptin for Treating Human Lipoatrophy and Method of Determining Predisposition to Said Treatment
12/15/2011	US20110306539 Process for making particles for delivery of drug nanoparticles
12/15/2011	US20110305782 Methods of cholesterol reduction using isoflavones
12/15/2011	US20110305777 Dimeric iap antagonists
12/15/2011	US20110305776 Thiochromene derivatives as hif hydroxylase inhibitors
12/15/2011	US20110305773 Approach to the treatment of compartment syndrome
12/15/2011	US20110305771 Krill Extracts for Treatment of Cardiovascular Diseases
12/15/2011	US20110305770 Releasable polymeric lipids for nucleic acids delivery system
12/15/2011	US20110305768 Quick-dissolving oral thin film for targeted delivery of therapeutic agents
12/15/2011	US20110305767 Polymer Particles Prepared From Polymerisable Alkylene Glycol (Meth) Acrylate Monomers

1 ... 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 ... 3163